BioHarvest Sciences Inc.
CNVCF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.73 | -1.00 | -0.99 | 0.15 |
| FCF Yield | -13.33% | -10.53% | -5.38% | -6.61% |
| EV / EBITDA | -9.42 | -11.90 | -17.95 | -10.76 |
| Quality | ||||
| ROIC | -105.45% | -156.94% | -110.69% | -165.35% |
| Gross Margin | 44.45% | 22.17% | 31.87% | 34.85% |
| Cash Conversion Ratio | 0.68 | 0.82 | 0.69 | 0.59 |
| Growth | ||||
| Revenue 3-Year CAGR | 82.00% | 140.35% | 112.84% | -4.10% |
| Free Cash Flow Growth | 4.77% | -24.46% | -108.35% | -67.48% |
| Safety | ||||
| Net Debt / EBITDA | -1.74 | -0.97 | 0.21 | -0.16 |
| Interest Coverage | -10.65 | -20.89 | -10.55 | -10.09 |
| Efficiency | ||||
| Inventory Turnover | 2.85 | 3.11 | 1.54 | 2.58 |
| Cash Conversion Cycle | 63.24 | 74.46 | 121.17 | -147.65 |